Congo's Mpox Vaccination Campaign Faces Awareness Hurdles
The Democratic Republic of Congo is experiencing challenges in its mpox vaccination campaign due to low public awareness and suspicion about the vaccine. Efforts are underway to improve awareness and boost vaccine uptake in areas heavily affected by the outbreak. Limited vaccine supply compounds the issue.
The Democratic Republic of Congo's efforts to combat the mpox outbreak face significant hurdles due to low public awareness and skepticism regarding the vaccine, officials have warned. The country's vaccination campaign has just started but needs greater outreach to succeed.
The initial phase of the mpox vaccination campaign in the eastern provinces has highlighted the limited knowledge about the disease and the availability of vaccines. Local health leaders, like Cris Kacita, stress the importance of filling these awareness gaps to increase vaccine acceptance among communities.
Despite targeting regions hit hardest by the outbreak, misinformation persists, particularly in displacement camps like Kibati. With limited vaccine doses available, advocates like Benire Furahini Buchaguzi are working tirelessly to promote immunization benefits and garner community trust.
(With inputs from agencies.)
ALSO READ
China Halts Imports from Poland and Croatia Amid Bluetongue Outbreak
Alphabet's Next Big Bet: AI in Online Search and Healthcare
Gisborne Hospital Unveils New Acute Mental Health Unit: Te Whare Awhi Ora
Iwi Māori Partnership Boards Deliver 15 Community Health Plans to Govt
Court Blocks Dreamers' Health Coverage in 19 States